FHD-286

CAS No. 2671128-05-3

FHD-286( —— )

Catalog No. M28880 CAS No. 2671128-05-3

FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 359 In Stock
5MG 282 In Stock
10MG 454 In Stock
25MG 616 In Stock
50MG 760 In Stock
100MG 1042 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FHD-286
  • Note
    Research use only, not for human use.
  • Brief Description
    FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
  • Description
    FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
  • In Vitro
    ——
  • In Vivo
    Animal Model:B16F10 tumor-bearing miceDosage:1.5 mg/kg Administration:Oral administration; for 10 days Result:Increased in IFNγ and Th1-type chemokine CXCL10 levels.
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2671128-05-3
  • Formula Weight
    562.66
  • Molecular Formula
    C24H30N6O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (444.32 mM)
  • SMILES
    C[C@H](C1)O[C@@H](C)CN1c1cccc(-c2csc(NC([C@H](COC)NC(c(cc3)cn3S(C)(=O)=O)=O)=O)n2)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Qiao J, et al. Identification of a Novel Specific Cucurbitadienol Synthase Allele in Siraitia grosvenorii Correlates with High Catalytic Efficiency. Molecules. 2019 Feb 11;24(3).
molnova catalog
related products
  • JWG-071

    JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.

  • NEO2734

    NEO2734 is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains).

  • DC-BPi-03

    DC-BPi-03 is a potent BPTF-BRD inhibitor, exhibiting an IC50 of 698.3 nM and a Kd of 2.81 μM.